IsoRay (ISR) Soars 250% YTD: Will The Rally Continue?

One of the stocks to have emerged as a notable gainer in 2021 so far is that of medical technology company IsoRay, Inc. (NYSE: ISR). The stock has managed to record gains of as big as 250% so far this year and it is perhaps a good time for investors to start looking into the company a bit more closely.

One of the latest triggers behind the rally in the Isoray stock came last week when the company announced the pricing for the upcoming public offering of its common stock.

Related:  Avinger (AVGR) Pulls Back From New Highs: A Good Buy?

Back on February 4, the company announced that it is going to offer as many as 36 million shares of its stock to the public at $1.25 each. The company is looking to raise about $45 million from this particular stock offering and the announcement of the pricing has led to considerable excitement among investors. The offering in question is going to close today and it might be a good move for investors to keep an eye on the stock.

Related:  Aptorum (APM) Gets Bullish Momentum From the FDA News

Michael Rowels

Weekend Contributor. Writing for business and finance publishers has become his passion over the last decades after he completed a master's degree in Financial Management. Sharing some opinions and forecasts to thousands of readers is a routine job for him but he never promises to invest in one stock.